Article
The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.
Drug metabolism reviews - 1 Feb 2017
Sak Katrin
Abstract excerpt
Catechol-O-methyltransferase, COMT, is an important phase II enzyme catalyzing the transfer of a methyl-group from S-adenosylmethionine to a catechol-containing substrate molecule. A genetic variant Val158Met in the COMT gene leads to a several-fold decrease in the enzymatic activity giving rise to the accumulation of potentially carcinogenic endogenous catechol estrogens and their reactive intermediates and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
